Back to Results
First PageMeta Content



A Phase 1b Study of the Anti-Cancer Stem Cell Agent Demcizumab (DEM, anti-DLL4) and Gemcitabine (GEM) with or without Nab-Paclitaxel in Patients with Pancreatic Cancer Dose Level – mg/kg Median age (years)
Add to Reading List

Document Date: 2016-01-22 10:42:40


Open Document

File Size: 691,25 KB

Share Result on Facebook